Ambarani, Anesan .

HRN: 26-30-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
08/05/2025
08/07/2025
ORAL
5ml
BID
AGE; For Deworming
Checking Initial Appropriateness 
08/06/2025
CEFUROXIME 750MG (VIAL)
08/06/2025
08/13/2025
IV
200mg
Q8hours
PCAP-B
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: